Human Capital Disclosure Assessment
Sumitomo Pharma Co.,Ltd.
Assessment Scores
Company coverage reference date: 2026-08-31
Overall Score
| Disclosure Governance | 18.75 / 20 |
|---|---|
| Human Intangible Assets | 36.25 / 40 |
| Technical Knowledge | 10.0 / 10 |
| Skills | 12.5 / 15 |
| Motivation | 13.75 / 15 |
| Human Capital Investment Flow | 15.0 / 40 |
Overall Disclosure Profile
Sumitomo Pharma Co.,Ltd. has established a research project system where researchers lead proposed themes, with discretion over budget execution and personnel evaluations. Experience leading teams from early- through late-stage research connects drug discovery with leadership development. Under this system, 11 compounds entered clinical stages, while more than 15 projects remain underway. The filing also discloses developing 108 personnel capable of independently improving workplace efficiency with digital tools.
Systems supporting employee challenges include compensation based on roles and outcomes, internal job postings, and dialogue with supervisors. The engagement score, calculated from fulfillment and willingness to contribute among other factors, rose from 44% to 58%. However, no comparison with the period before the system's introduction is provided for the 11 compounds entering clinical stages, nor is their profit contribution disclosed. Disclosure of analysis identifying each initiative's contribution to changes in motivation is also limited.
Scores by Assessment Item
Scores assess disclosures in the Annual Securities Report. A score of zero does not mean that an initiative is not implemented or that employees lack capability.
| Disclosure Governance | |
|---|---|
| G1Disclosure of Basic Quantitative Information | 5 / 5 |
| G2Governance and Risk Management | 5.0 / 5 |
| G3Human Capital Strategy and Basic Policy | 5.0 / 5 |
| G4Clarity of Indicators, Targets, and Explanations | 3.75 / 5 |
| Human Intangible Assets | |
| Technical Knowledge | |
| T1Technical Knowledge Base | 5.0 / 5 |
| T2Acquisition and Accumulation of Technical Knowledge | 5.0 / 5 |
| Skills | |
| S1Alignment between Technical Knowledge and Practical Work | 5.0 / 5 |
| S2Volume of Use and Application | 3.75 / 5 |
| S3Continued Use and Expansion | 3.75 / 5 |
| Motivation | |
| M1Mechanisms Supporting Motivation | 5.0 / 5 |
| M2Track Record of Operation | 5.0 / 5 |
| M3Employee State and Change | 3.75 / 5 |
| Human Capital Investment Flow | |
| F1Logic from Investment to Outcomes | 7.5 / 10 |
| F2Magnitude of Outcomes | 5.0 / 10 |
| F3Calculation Basis and Use in Planning | 0.0 / 10 |
| F4Verification of the Relationship | 2.5 / 10 |
Assessment History
2025-04-01 – 2026-03-31 · Latest recorded assessment
No earlier assessments are recorded. Comparability across periods has not been confirmed.
Sources & Assessment Scope
Current Company Information
Filing Information
Assessment Scope & Disclaimer
This assessment is based solely on information disclosed in the company's Japanese-language Annual Securities Report filed through EDINET.
It does not assess the human capital initiatives a company actually implements or the company's human capital capabilities themselves.
Items for which no disclosure was identified in the Annual Securities Report receive no points, regardless of whether the company actually implements the relevant initiatives.
This English-language assessment is a translation of the original Japanese assessment and is provided for convenience. In the event of any discrepancy, the Japanese assessment prevails.